| Ryan Patrick Morton, MD | |
|
3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 | |
| (574) 847-9065 | |
| Not Available |
| Full Name | Ryan Patrick Morton |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 15 Years |
| Location | 3551 Roger Brooke Dr, Fort Sam Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922239268 | NPI | - | NPPES |
| 380930301 | Medicaid | TX | |
| 380930302 | Other | TX | CSHCN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | ML60087055 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospital | San antonio, TX | Hospital |
| Christus Santa Rosa Medical Center | San antonio, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neurosurgical Associates Of San Antonio, P.a. | 9638151954 | 14 |
| Tn Spine Pllc | 2769783505 | 14 |
News Archive
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
The job of implementing a key Obama administration health reform -;a statewide marketplace where consumers and businesses can buy affordable health insurance-;would be turned over to a non-profit company under proposed legislation announced today by Michigan's Republican Gov. Rick Snyder.
Cepheid today announced an exclusive collaboration with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Together with other lab tests, monitoring levels of BCR-ABL transcripts in Ph+ CML patients will aid in patient management.
Generex Biotechnology Corporation announced today that Stamford Hospital has agreed to participate in the United States Food and Drug Administration Expanded Access Treatment Investigational New Drug Program for Generex Oral-lyn, the Company's proprietary buccal insulin spray product for the treatment of patients with diabetes.
The median profit margin of U.S. hospitals increased from 0.17 percent in the third quarter of 2008 to 3.1 percent in the first quarter of 2009, according to an analysis of hospital finances published today by Thomson Reuters.
› Verified 6 days ago
| Entity Name | Neurosurgical Associates Of San Antonio, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447295753 PECOS PAC ID: 9638151954 Enrollment ID: O20040602000176 |
News Archive
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
The job of implementing a key Obama administration health reform -;a statewide marketplace where consumers and businesses can buy affordable health insurance-;would be turned over to a non-profit company under proposed legislation announced today by Michigan's Republican Gov. Rick Snyder.
Cepheid today announced an exclusive collaboration with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Together with other lab tests, monitoring levels of BCR-ABL transcripts in Ph+ CML patients will aid in patient management.
Generex Biotechnology Corporation announced today that Stamford Hospital has agreed to participate in the United States Food and Drug Administration Expanded Access Treatment Investigational New Drug Program for Generex Oral-lyn, the Company's proprietary buccal insulin spray product for the treatment of patients with diabetes.
The median profit margin of U.S. hospitals increased from 0.17 percent in the third quarter of 2008 to 3.1 percent in the first quarter of 2009, according to an analysis of hospital finances published today by Thomson Reuters.
› Verified 6 days ago
| Entity Name | University Of Texas Health Science Center At San Antonio |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720051717 PECOS PAC ID: 0042128548 Enrollment ID: O20040607000664 |
News Archive
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
The job of implementing a key Obama administration health reform -;a statewide marketplace where consumers and businesses can buy affordable health insurance-;would be turned over to a non-profit company under proposed legislation announced today by Michigan's Republican Gov. Rick Snyder.
Cepheid today announced an exclusive collaboration with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Together with other lab tests, monitoring levels of BCR-ABL transcripts in Ph+ CML patients will aid in patient management.
Generex Biotechnology Corporation announced today that Stamford Hospital has agreed to participate in the United States Food and Drug Administration Expanded Access Treatment Investigational New Drug Program for Generex Oral-lyn, the Company's proprietary buccal insulin spray product for the treatment of patients with diabetes.
The median profit margin of U.S. hospitals increased from 0.17 percent in the third quarter of 2008 to 3.1 percent in the first quarter of 2009, according to an analysis of hospital finances published today by Thomson Reuters.
› Verified 6 days ago
| Entity Name | Tn Spine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407226962 PECOS PAC ID: 2769783505 Enrollment ID: O20151221000302 |
News Archive
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
The job of implementing a key Obama administration health reform -;a statewide marketplace where consumers and businesses can buy affordable health insurance-;would be turned over to a non-profit company under proposed legislation announced today by Michigan's Republican Gov. Rick Snyder.
Cepheid today announced an exclusive collaboration with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Together with other lab tests, monitoring levels of BCR-ABL transcripts in Ph+ CML patients will aid in patient management.
Generex Biotechnology Corporation announced today that Stamford Hospital has agreed to participate in the United States Food and Drug Administration Expanded Access Treatment Investigational New Drug Program for Generex Oral-lyn, the Company's proprietary buccal insulin spray product for the treatment of patients with diabetes.
The median profit margin of U.S. hospitals increased from 0.17 percent in the third quarter of 2008 to 3.1 percent in the first quarter of 2009, according to an analysis of hospital finances published today by Thomson Reuters.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Patrick Morton, MD 3551 Roger Brooke Dr, San Antonio, TX 78234-4504 Ph: (574) 847-9065 | Ryan Patrick Morton, MD 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 Ph: (574) 847-9065 |
News Archive
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
The job of implementing a key Obama administration health reform -;a statewide marketplace where consumers and businesses can buy affordable health insurance-;would be turned over to a non-profit company under proposed legislation announced today by Michigan's Republican Gov. Rick Snyder.
Cepheid today announced an exclusive collaboration with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Together with other lab tests, monitoring levels of BCR-ABL transcripts in Ph+ CML patients will aid in patient management.
Generex Biotechnology Corporation announced today that Stamford Hospital has agreed to participate in the United States Food and Drug Administration Expanded Access Treatment Investigational New Drug Program for Generex Oral-lyn, the Company's proprietary buccal insulin spray product for the treatment of patients with diabetes.
The median profit margin of U.S. hospitals increased from 0.17 percent in the third quarter of 2008 to 3.1 percent in the first quarter of 2009, according to an analysis of hospital finances published today by Thomson Reuters.
› Verified 6 days ago
Dr. Ian S. Mcdougall, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 | |
Geoffrey William Peitz, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-3482 | |
Grant W Mallory, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-3482 | |
Victor Sabourin, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 |